Neurocrine Bio. (NBIX) Price Target Lifte at Cowen Following Dinner With Management
Tweet Send to a Friend
Cowen analyst Phil Nadeau reiterated an Outperform rating and lifted his price target on Neurocrine Bio. (NASDAQ: NBIX) to $45.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
